XRCC3 and ovarian carcinoma: We screened the RAD51, XRCC3, and XRCC2 genes for germline variation in familial BRCA1/2-negative breast or ovarian cancer patients in order to evaluate the role of these genes in breast cancer predisposition in Finland and to identify putative recurrent founder mutations.